Revitalizing Periodontal Therapy: Unveiling the Power of Growth Factor Enhanced Matrix 21s in Clinical Practice – A Literature Review

Periodontal regeneration therapy attempts to revive the lost structures of the periodontium, which includes the gingiva, periodontal ligament (PDL), cementum, and alveolar bone, which get affected due to periodontal disease. One innovative approach for periodontal regeneration therapy is to use growth factors, particularly recombinant human platelet-derived growth factor (rhPDGF). GEM 21S, a product that combines rhPDGF-BB with a collagen matrix, has shown significant potential in enhancing periodontal regeneration. GEM 21S enhances the proliferation of periodontal ligament (PDL) cells, stimulates the differentiation of osteoblast cells, and supports the regeneration of key periodontal tissues. Clinical studies suggest that GEM 21S contributes to increased bone formation, improved attachment levels, and better overall clinical outcomes in periodontal defect treatment. While the results are promising, long-term research is needed to establish the prolonged effectiveness and cost-benefit profile of GEM 21S as a regenerative treatment option for periodontal disease.